
Vice President, Corporate Securities and Transactions
Allogene Therapeutics$3,40,000 – $3,80,000 / वर्ष
हाइब्रिडपूर्णकालिकलीडआवश्यक भाषा: अंग्रेज़ीउपाध्यक्षLead SEC reporting, corporate governance, and strategic transaction matters for Allogene Therapeutics, a clinical-stage biotechnology company developing off-the-shelf CAR T therapies.
खोलें